Search

everythinglearnresearchcommunity

for

Search:↓

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

High TNF-α levels may increase hair loss risk after PRP therapy.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Indian dermatosurgical practitioners were given guidelines in 2011 to reduce infection risks, including hand hygiene, sterilization methods, operation theater standards, and proper waste disposal.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

HIV-infected men who have sex with men are at higher risk for aggressive syphilis, but treatment and tests are effective.

Isotretinoin can safely and effectively control acne with proper risk management and monitoring.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

The method accurately detects diabetes with 94% effectiveness, reducing misdiagnosis risk.

Finasteride helps improve hair growth in men with hair loss but may increase the risk of erectile dysfunction.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Biologics for severe asthma have known side effects, but some new risks need more study.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.